446 related articles for article (PubMed ID: 12051689)
1. Effect of pyridoxamine on chemical modification of proteins by carbonyls in diabetic rats: characterization of a major product from the reaction of pyridoxamine and methylglyoxal.
Nagaraj RH; Sarkar P; Mally A; Biemel KM; Lederer MO; Padayatti PS
Arch Biochem Biophys; 2002 Jun; 402(1):110-9. PubMed ID: 12051689
[TBL] [Abstract][Full Text] [Related]
2. Pyridoxamine inhibits maillard reactions in diabetic rat lenses.
Padival S; Nagaraj RH
Ophthalmic Res; 2006; 38(5):294-302. PubMed ID: 16974131
[TBL] [Abstract][Full Text] [Related]
3. Chemical modification of proteins by methylglyoxal.
Degenhardt TP; Thorpe SR; Baynes JW
Cell Mol Biol (Noisy-le-grand); 1998 Nov; 44(7):1139-45. PubMed ID: 9846896
[TBL] [Abstract][Full Text] [Related]
4. Maillard reactions in lens proteins: methylglyoxal-mediated modifications in the rat lens.
Shamsi FA; Sharkey E; Creighton D; Nagaraj RH
Exp Eye Res; 2000 Mar; 70(3):369-80. PubMed ID: 10712823
[TBL] [Abstract][Full Text] [Related]
5. Methylglyoxal-derived modifications in lens aging and cataract formation.
Shamsi FA; Lin K; Sady C; Nagaraj RH
Invest Ophthalmol Vis Sci; 1998 Nov; 39(12):2355-64. PubMed ID: 9804144
[TBL] [Abstract][Full Text] [Related]
6. Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat.
Degenhardt TP; Alderson NL; Arrington DD; Beattie RJ; Basgen JM; Steffes MW; Thorpe SR; Baynes JW
Kidney Int; 2002 Mar; 61(3):939-50. PubMed ID: 11849448
[TBL] [Abstract][Full Text] [Related]
7. Methylglyoxal inhibits glycation-mediated loss in chaperone function and synthesis of pentosidine in alpha-crystallin.
Puttaiah S; Biswas A; Staniszewska M; Nagaraj RH
Exp Eye Res; 2007 May; 84(5):914-21. PubMed ID: 17368444
[TBL] [Abstract][Full Text] [Related]
8. The AGE inhibitor pyridoxamine inhibits lipemia and development of renal and vascular disease in Zucker obese rats.
Alderson NL; Chachich ME; Youssef NN; Beattie RJ; Nachtigal M; Thorpe SR; Baynes JW
Kidney Int; 2003 Jun; 63(6):2123-33. PubMed ID: 12753299
[TBL] [Abstract][Full Text] [Related]
9. Protein modification by methylglyoxal: chemical nature and synthetic mechanism of a major fluorescent adduct.
Shipanova IN; Glomb MA; Nagaraj RH
Arch Biochem Biophys; 1997 Aug; 344(1):29-36. PubMed ID: 9244378
[TBL] [Abstract][Full Text] [Related]
10. Pyridoxamine improves functional, structural, and biochemical alterations of peritoneal membranes in uremic peritoneal dialysis rats.
Kakuta T; Tanaka R; Satoh Y; Izuhara Y; Inagi R; Nangaku M; Saito A; Miyata T
Kidney Int; 2005 Sep; 68(3):1326-36. PubMed ID: 16105068
[TBL] [Abstract][Full Text] [Related]
11. The Role of Oxidative Stress in Diabetic Neuropathy: Generation of Free Radical Species in the Glycation Reaction and Gene Polymorphisms Encoding Antioxidant Enzymes to Genetic Susceptibility to Diabetic Neuropathy in Population of Type I Diabetic Patients.
Babizhayev MA; Strokov IA; Nosikov VV; Savel'yeva EL; Sitnikov VF; Yegorov YE; Lankin VZ
Cell Biochem Biophys; 2015 Apr; 71(3):1425-43. PubMed ID: 25427889
[TBL] [Abstract][Full Text] [Related]
12. Advanced glycation endproducts in food and their effects on health.
Poulsen MW; Hedegaard RV; Andersen JM; de Courten B; Bügel S; Nielsen J; Skibsted LH; Dragsted LO
Food Chem Toxicol; 2013 Oct; 60():10-37. PubMed ID: 23867544
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of glyoxalase-I in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia-induced increases in macromolecular endocytosis.
Shinohara M; Thornalley PJ; Giardino I; Beisswenger P; Thorpe SR; Onorato J; Brownlee M
J Clin Invest; 1998 Mar; 101(5):1142-7. PubMed ID: 9486985
[TBL] [Abstract][Full Text] [Related]
14. Skin beautification with oral non-hydrolized versions of carnosine and carcinine: Effective therapeutic management and cosmetic skincare solutions against oxidative glycation and free-radical production as a causal mechanism of diabetic complications and skin aging.
Babizhayev MA; Deyev AI; Savel'yeva EL; Lankin VZ; Yegorov YE
J Dermatolog Treat; 2012 Oct; 23(5):345-84. PubMed ID: 21756141
[TBL] [Abstract][Full Text] [Related]
15. Interactions of the advanced glycation end product inhibitor pyridoxamine and the antioxidant alpha-lipoic acid on insulin resistance in the obese Zucker rat.
Muellenbach EA; Diehl CJ; Teachey MK; Lindborg KA; Archuleta TL; Harrell NB; Andersen G; Somoza V; Hasselwander O; Matuschek M; Henriksen EJ
Metabolism; 2008 Oct; 57(10):1465-72. PubMed ID: 18803954
[TBL] [Abstract][Full Text] [Related]
16. N-epsilon-(carboxyethyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins.
Ahmed MU; Brinkmann Frye E; Degenhardt TP; Thorpe SR; Baynes JW
Biochem J; 1997 Jun; 324 ( Pt 2)(Pt 2):565-70. PubMed ID: 9182719
[TBL] [Abstract][Full Text] [Related]
17. Role of the Maillard reaction in aging of tissue proteins. Advanced glycation end product-dependent increase in imidazolium cross-links in human lens proteins.
Frye EB; Degenhardt TP; Thorpe SR; Baynes JW
J Biol Chem; 1998 Jul; 273(30):18714-9. PubMed ID: 9668043
[TBL] [Abstract][Full Text] [Related]
18. Pyridoxamine reverts methylglyoxal-induced impairment of survival pathways during heart ischemia.
Almeida F; Santos-Silva D; Rodrigues T; Matafome P; Crisóstomo J; Sena C; Gonçalves L; Seiça R
Cardiovasc Ther; 2013 Dec; 31(6):e79-85. PubMed ID: 23841818
[TBL] [Abstract][Full Text] [Related]
19. Attenuation of hypertension development by scavenging methylglyoxal in fructose-treated rats.
Wang X; Jia X; Chang T; Desai K; Wu L
J Hypertens; 2008 Apr; 26(4):765-72. PubMed ID: 18327087
[TBL] [Abstract][Full Text] [Related]
20. Pyridoxamine, an inhibitor of advanced glycation reactions, also inhibits advanced lipoxidation reactions. Mechanism of action of pyridoxamine.
Onorato JM; Jenkins AJ; Thorpe SR; Baynes JW
J Biol Chem; 2000 Jul; 275(28):21177-84. PubMed ID: 10801874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
